Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
05/2000
05/11/2000WO2000025758A1 Oral administration of adenosine analogs
05/11/2000WO2000011968A8 ANTIOXIDANT COMPOSITION COMPRISING ACETYL L-CARNITINE AND α-LIPOIC ACID
05/11/2000WO2000009099A3 Treatment of vasodilatory headache
05/11/2000WO2000008007A3 Cyclopentabenzofuran derivatives and their use
05/11/2000WO2000007581A3 Antioxidant, antiproliferous composition, comprising a carnitine and a carotenoid
05/11/2000WO2000007565A3 Methods of ophthalmic administration
05/11/2000WO2000000238A9 Topoisomerase inhibitors for prevention of restenosis
05/11/2000WO1999060984A3 Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using serine proteases
05/11/2000WO1999053036A3 Ste20-related protein kinases
05/11/2000DE19851184A1 N-Arylsulfonyl-aminosäure-omega-amide N-arylsulfonyl-amino-omega-amides
05/11/2000DE19850701A1 Benzoylpyridazine Benzoylpyridazine
05/11/2000CA2350052A1 Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same
05/11/2000CA2349818A1 Membrane transport proteins
05/11/2000CA2349758A1 A method for inhibition of phospholamban activity for the treatment of cardiac disease and heart failure
05/11/2000CA2349567A1 Pyrazolopyridine derivatives as selective cox-2 inhibitors
05/11/2000CA2349504A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/11/2000CA2349232A1 Benzoylpyridazines
05/11/2000CA2349212A1 Myosin heavy chain homolog
05/11/2000CA2348879A1 Pyrrolidine compound and pharmaceutical use thereof
05/11/2000CA2348728A1 Method for the production of quercetin and isoquercetin derivatives
05/11/2000CA2348703A1 Inhibitors of prenyl-protein transferase
05/11/2000CA2348446A1 Benzamide potassium channel inhibitors
05/11/2000CA2348392A1 Method for producing luteolin and luteolin derivatives
05/11/2000CA2347650A1 Transmembrane 4 proteins
05/11/2000CA2347188A1 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/11/2000CA2347102A1 Compounds with growth hormone releasing properties
05/11/2000CA2347060A1 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/11/2000CA2317117A1 Ldl related protein and uses thereof
05/11/2000CA2312430A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity
05/10/2000EP0998569A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
05/10/2000EP0998556A2 Diagnosis and treatment of diseases using anti-t-cell receptor vbeta antibodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein 1 (esrp1)
05/10/2000EP0998477A1 Alkyl-4-silylheterocyclic phenols and thiophenols as antioxidant agents
05/10/2000EP0998475A1 Novel compounds
05/10/2000EP0998474A1 Piperazine derivatives
05/10/2000EP0998473A1 Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
05/10/2000EP0998471A1 Substituted heterocyclic compounds, method for preparing and compositions containing same
05/10/2000EP0998460A1 Novel tetrazole derivatives
05/10/2000EP0998459A2 Pyridine derivatives
05/10/2000EP0998307A2 METHOD FOR TREATING VASCULAR PROLIFERATIVE DISEASES WITH p27 AND FUSIONS THEREOF
05/10/2000EP0998300A1 Methods and compositions for modulating responsiveness to corticosteroids
05/10/2000EP0998282A1 Sulfonamides as cell adhesion inhibitors
05/10/2000EP0998275A1 INHIBITION OF NUCLEAR TRANSCRIPTION FACTOR NF-kappaB BY CAFFEIC ACID PHENETHYL ESTER (CAPE), DERIVATIVES OF CAPE, CAPSAICIN (8-METHYL-N-VANILLYL-6-NONENAMIDE) AND RESINIFERATOXIN
05/10/2000EP0820428B1 Terminal carboxy or tetrazole groups containing dialkyl ethers
05/10/2000EP0743939B1 Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists
05/10/2000EP0736004B1 (2,4-disulfophenyl) n-tertiary butyl nitrone, its salts, and their use as pharmaceutical radical trapping agents
05/10/2000EP0623019B1 Docosahexaenoic acid based drugs, for use as platelet aggregation inhibitors and against essential fatty acid deficiencies of the brain, and preparation processes.
05/10/2000CN1252810A Antibody for inhibiting blood coagulation and method of use thereof
05/10/2000CN1252799A N-heterocyclic derivatives as NOS inhibitor
05/10/2000CN1252798A Indazole amide compounds as 5-serotoninergic agents
05/10/2000CN1252792A Process and intermediates for the preparation of 4'-trifluoromethyl-bipheyl-2-carboxylic acid (1,2,3,4-tetrahydro-isoquinolin-6-yl)-amide
05/10/2000CN1252790A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
05/10/2000CN1252726A Methods for treating vascular disorders
05/10/2000CN1252723A Use of 7 alpha-methyl-17 alpha-ethyle-estrane derivative for treatment of atherosclerosis
05/10/2000CN1252721A Pharmaceutical composition
05/10/2000CN1252716A Inhibitor of leaderless protein export
05/10/2000CN1252713A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
05/10/2000CN1252277A Quick soluble breviscapine B tablet and its preparation
05/10/2000CN1252238A Stable powder tomato red agent preparation containing crystallinity large than 20% tomato red agent
05/10/2000CN1052231C 2-oxo-5-oxazolidone methyl compound their preparing method and medicinal composition containing them
05/10/2000CN1052227C Oxazolidone used as adhesive receptor antagenists, its preparing method and medicinal composition containing them
05/10/2000CN1052218C Process for preparing substituted 2-amino tetrahydronaphthalenes and 3-aminochromans
05/09/2000US6060508 Benzylamine derivatives, their preparation and their application in therapeutics
05/09/2000US6060479 Quinazoline-4-one AMPA antagonists
05/09/2000US6060475 Substituted pyrazin-2-yl-sulphonamide-(3-pyridyl) compounds and uses thereof
05/09/2000US6060464 Compounds and pharmaceutical compositions containing them
05/09/2000US6060454 Administering beta-blocker and atrioventricular node blocker to induce reversible ventricular asystole
05/09/2000US6060446 Protein and carnosine, glutathione, and/or cyclo-histidine-proline
05/09/2000US6060239 Cellubrevin homologs
05/09/2000CA2151560C Insulin analog formulations
05/09/2000CA2112239C Enantiomeric hydroxylated xanthine compounds
05/09/2000CA1340985C Peptide derivatives
05/04/2000WO2000024911A2 Human phospholipases
05/04/2000WO2000024901A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000WO2000024897A1 Cell surface molecule-induced macrophage activation
05/04/2000WO2000024886A1 Prv-1 gene and the use thereof
05/04/2000WO2000024885A2 p53 MORPHOLINO-BASED ANTISENSE
05/04/2000WO2000024781A1 Conformation-specific anti-von willebrand factor antibodies
05/04/2000WO2000024745A1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION
05/04/2000WO2000024744A1 Bicyclic nitrogen heterocycles
05/04/2000WO2000024743A1 Pyrano, piperidino, and thiopyrano compounds and methods of use
05/04/2000WO2000024742A1 Pyrazolopyridine as adenosine antagonists
05/04/2000WO2000024741A2 Dihydropyridine compounds and their use as potassium channel openers
05/04/2000WO2000024724A1 Thiazole-derivatives
05/04/2000WO2000024718A1 Serine protease inhibitor
05/04/2000WO2000024714A1 Intermediate for the synthesis of amlodipine, preparation process and corresponding utilization
05/04/2000WO2000024710A1 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
05/04/2000WO2000024707A1 Substituted phenyl derivatives, their preparation and use
05/04/2000WO2000024452A1 Systems and compounds for drug delivery to interstitial regions of the myocardium
05/04/2000WO2000024403A1 Use of antifungal agents for treating scleroses
05/04/2000WO2000024402A1 Use of antifungal agents for treating scleroses
05/04/2000WO2000024398A1 Benzoazepines and analogs thereof useful as growth hormone secretagogues
05/04/2000WO2000024386A1 Method of making pressure sensitive adhesive matrix patches containing hydrophilic salts of drugs
05/04/2000WO2000012741A3 Inducible expression system
05/04/2000WO2000012139B1 Hypoxia regulated genes
05/04/2000WO2000006730A3 Human cytoskeletal proteins
05/04/2000WO2000006187A3 Modulation of apoptosis
05/04/2000WO2000006085A3 Compounds and methods
05/04/2000WO2000004868A3 Libraries of polyhydroxamates and their analogs
05/04/2000WO2000004862A3 Bioenhanced formulations comprising eprosartan in oral solid dosage form
05/04/2000WO2000003677A3 Use of bisphosphonates in the treatment of vascular restenosis
1 ... 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 ... 1595